Revance Therapeutics, Inc.
RVNC · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$42 | -$37 | -$50 | -$56 |
| Dep. & Amort. | $1 | $1 | $2 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5 | $6 | $9 | $9 |
| Change in WC | $34 | -$11 | -$23 | $3 |
| Other Non-Cash | -$39 | $20 | $20 | $3 |
| Operating Cash Flow | -$41 | -$41 | -$66 | -$43 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$2 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$62 | -$92 | -$73 | -$84 |
| Inv. Sales/Matur. | $89 | $87 | $47 | $90 |
| Other Inv. Act. | -$4 | -$2 | -$3 | -$2 |
| Investing Cash Flow | $23 | -$7 | -$32 | $2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$6 | -$4 | -$4 | -$3 |
| Stock Issued | -$0 | $1 | $98 | $1 |
| Stock Repurch. | $0 | -$0 | $0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | $0 | -$1 | $1 |
| Financing Cash Flow | -$6 | -$3 | $93 | -$2 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$17 | -$51 | -$5 | -$42 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $88 | $133 | $138 | $180 |
| End Cash | $65 | $82 | $133 | $138 |
| Free Cash Flow | -$41 | -$42 | -$68 | -$45 |